1. Comparative Assessment of Reimbursement Recommendations by NICE and HAS for Oncology New Medicines Indicated for the Treatment of Solid Tumors from 2015 to 2021
2. National Institute for Health and Care Excellence. NICE health technology evaluations: the manual. 2022. Available from: https://www.nice.org.uk/process/pmg36/resources/nice-health-technology-evaluations-the-manual-pdf-72286779244741. [Accessed 27 October, 2023].
3. Haute Authorité de Santé. Avis et décisions sur les médicaments. Available from: https://www.has-sante.fr/jcms/p_3281266/en/avis-et-decisions-sur-les-medicaments. [Accessed 5 September, 2023].
4. Canadian Agency for Drugs and Technologies in Health. Reimbursement review reports. Available from: https://www.cadth.ca/reimbursement-review-reports. [Accessed 24 July, 2023].
5. The Pharmaceutical Benefits Scheme. PBAC outcomes. Available from: https://www.pbs.gov.au/pbs/industry/listing/elements/pbac-meetings/pbac-outcomes. [Accessed 5 September, 2023].